As of 9:30 AM on the 8th, Celltrion is trading at 260,500 KRW, up 1.56% from the previous day. This represents a 23.75% increase compared to May 11. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net sold 873,322 shares, while foreigners and institutions have net bought 699,698 shares and 255,842 shares, respectively.

On June 5, Celltrion was a market topic with the headline "Ramsima SC efficacy confirmation news leads to a two-day surge."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing